These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
732 related articles for article (PubMed ID: 3039108)
1. Naloxonazine effects on the interaction of enkephalin analogs with mu-1, mu and delta opioid binding sites in rat brain membranes. Cruciani RA; Lutz RA; Munson PJ; Rodbard D J Pharmacol Exp Ther; 1987 Jul; 242(1):15-20. PubMed ID: 3039108 [TBL] [Abstract][Full Text] [Related]
2. Opioid binding to rat and guinea-pig neural membranes in the presence of physiological cations at 37 degrees C. Werling LL; Zarr GD; Brown SR; Cox BM J Pharmacol Exp Ther; 1985 Jun; 233(3):722-8. PubMed ID: 2989494 [TBL] [Abstract][Full Text] [Related]
3. A quantitative study of [3H]D-Ala2-D-Leu5-enkephalin binding to rat brain membranes. Evidence that oxymorphone is a noncompetitive inhibitor of the lower affinity delta-binding site. Rothman RB; Bowen WD; Herkenham M; Jacobson AE; Rice KC; Pert CB Mol Pharmacol; 1985 Mar; 27(3):399-409. PubMed ID: 2579319 [TBL] [Abstract][Full Text] [Related]
4. Antagonist-induced opioid receptor up-regulation. II. Regionally specific modulation of mu, delta and kappa binding sites in rat brain revealed by quantitative autoradiography. Morris BJ; Millan MJ; Herz A J Pharmacol Exp Ther; 1988 Nov; 247(2):729-36. PubMed ID: 2846828 [TBL] [Abstract][Full Text] [Related]
5. Opiate binding in calf thalamic membranes: a selective mu 1 binding assay. Clark JA; Houghten R; Pasternak GW Mol Pharmacol; 1988 Sep; 34(3):308-17. PubMed ID: 2901663 [TBL] [Abstract][Full Text] [Related]
6. Biochemical characterization of high-affinity 3H-opioid binding. Further evidence for Mu1 sites. Nishimura SL; Recht LD; Pasternak GW Mol Pharmacol; 1984 Jan; 25(1):29-37. PubMed ID: 6323950 [TBL] [Abstract][Full Text] [Related]
7. Cystamine-enkephalin dimer. Syntheses and biological activities of enkephalin analogs containing cystamine and cysteamine. Kondo M; Kodama H; Costa T; Shimohigashi Y Int J Pept Protein Res; 1986 Feb; 27(2):153-9. PubMed ID: 3009340 [TBL] [Abstract][Full Text] [Related]
8. Sodium regulation of agonist binding at opioid receptors. I. Effects of sodium replacement on binding at mu- and delta-type receptors in 7315c and NG108-15 cells and cell membranes. Puttfarcken P; Werling LL; Brown SR; Cote TE; Cox BM Mol Pharmacol; 1986 Aug; 30(2):81-9. PubMed ID: 3016503 [TBL] [Abstract][Full Text] [Related]
9. Characterization of D-Ala2,Leu5,Cys6-enkephalin: a novel synthetic opioid peptide with slowed dissociation from delta receptors. Bowen WD; Kelemen M; Huey R; Stewart D NIDA Res Monogr; 1986; 75():193-6. PubMed ID: 2828971 [TBL] [Abstract][Full Text] [Related]
10. Opiate receptor binding characteristics of dimeric analogues of mu-selective DAGO-enkephalin. Shimohigashi Y; Waki M; Izumiya N; Costa T; Herz A; Kurono M; Yagi K Biochem Int; 1986 Aug; 13(2):199-203. PubMed ID: 3021160 [TBL] [Abstract][Full Text] [Related]
11. Reversible and irreversible binding of beta-funaltrexamine to mu, delta and kappa opioid receptors in guinea pig brain membranes. Tam SW; Liu-Chen LY J Pharmacol Exp Ther; 1986 Nov; 239(2):351-7. PubMed ID: 3021954 [TBL] [Abstract][Full Text] [Related]
12. beta-FNA binds irreversibly to the opiate receptor complex: in vivo and in vitro evidence. Rothman RB; Long JB; Bykov V; Jacobson AE; Rice KC; Holaday JW J Pharmacol Exp Ther; 1988 Nov; 247(2):405-16. PubMed ID: 2846819 [TBL] [Abstract][Full Text] [Related]
13. Multiple opiate binding sites in the central nervous system of the rabbit. Large predominance of a mu subtype in the cerebellum and characterization of a kappa subtype in the thalamus. Meunier JC; Kouakou Y; Puget A; Moisand C Mol Pharmacol; 1983 Jul; 24(1):23-9. PubMed ID: 6306437 [TBL] [Abstract][Full Text] [Related]
14. A novel phencyclidine analog interacts selectively with mu opioid receptors. Itzhak Y; Simon EJ J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884 [TBL] [Abstract][Full Text] [Related]
15. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition. Liu-Chen LY; Yang HH; Li S; Adams JU J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074 [TBL] [Abstract][Full Text] [Related]
16. Cross-linking of human [125I]beta-endorphin to opioid receptors in rat striatal membranes: biochemical evidence for the existence of a mu/delta opioid receptor complex. Schoffelmeer AN; Yao YH; Gioannini TL; Hiller JM; Ofri D; Roques BP; Simon EJ J Pharmacol Exp Ther; 1990 Apr; 253(1):419-26. PubMed ID: 2158552 [TBL] [Abstract][Full Text] [Related]
17. The role of mu- and delta- opioid receptors on the intestinal propulsion in rats. Sbacchi M; La Regina A; Petrillo P; Tavani A NIDA Res Monogr; 1986; 75():520-3. PubMed ID: 2828999 [TBL] [Abstract][Full Text] [Related]
18. Sodium regulation of agonist binding at opioid receptors. II. Effects of sodium replacement on opioid binding in guinea pig cortical membranes. Werling LL; Brown SR; Puttfarcken P; Cox BM Mol Pharmacol; 1986 Aug; 30(2):90-5. PubMed ID: 3016504 [TBL] [Abstract][Full Text] [Related]
19. Comparison of [125I]beta-endorphin binding to rat brain and NG108-15 cells using a monoclonal antibody directed against the opioid receptor. Bidlack JM; O'Malley WE; Schulz R Mol Pharmacol; 1988 Feb; 33(2):170-7. PubMed ID: 2828912 [TBL] [Abstract][Full Text] [Related]
20. Effects of calcium-channel blockers (CCB) on mu and delta opioid receptors in rat brain membranes. Schwarz S; Katki AG Prog Clin Biol Res; 1990; 328():109-12. PubMed ID: 2154761 [No Abstract] [Full Text] [Related] [Next] [New Search]